A recent report by Saint-Paul et al found that PTPRC also known as CD45 is involved in the progression of AML through modification in plasma membrane bound lipid rafts, cholesterol and glycosphingo lipid enriched patches which is correlated from our results [37]. This evidence concerns the gene PTPRC and acute myeloid leukemia.